Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Off-Label Citations Disappear In Post-Caronia Enforcement Letters

May 06 2013

• By Sarah Karlin-Smith

Related Content

The Consequences of <em>Caronia</em>: Impact On FDA’s Off-Label Regulation

Jan 29 2013

FDA’s Promotional Assessments Reorganized Around Specialty, Not Target Audience

Mar 08 2013

Additional Topics

United States Advertising, Marketing & Sales Regulation Compliance Post Market Regulation & Studies Legal Issues BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window